Alpha Healthcare Acquisition Corp (AHACW)

Etorro trading 970x250

About Alpha Healthcare Acquisition Corp

Address: 1177 Avenue of The Americas, New York, NY, United States, 10105

Alpha Healthcare Acquisition Corp News and around…

Latest news about Alpha Healthcare Acquisition Corp (AHACW) common stock and company :

Humacyte Announces Successful Closing of Business Combination with Alpha Healthcare Acquisition Corp.
26 Aug, 2021 Yahoo! Finance

Kathleen Sebelius Chair of Humacyte's Board of Directors Dr. Laura Niklason Founder, President & CEO of Humacyte Rajiv Shukla CEO of Alpha Healthcare Acquisition Corp. Humacyte raises $245M gross proceedsCombined company is expected to begin trading on the Nasdaq Global Select Market® under “HUMA” and “HUMAW” on August 27, 2021Company well-positioned to deliver on promise of regenerative tissue HAV technology for initial indications in vascular trauma, AV access and peripheral arterial diseaseCo

Alpha Healthcare Acquisition Corp. Announces Shareholder Approval of Business Combination with Humacyte
24 Aug, 2021 Yahoo! Finance

NEW YORK and DURHAM, N.C., Aug. 24, 2021 (GLOBE NEWSWIRE) -- Alpha Healthcare Acquisition Corp. (Nasdaq: AHAC) (“AHAC”), a special purpose acquisition company, today announced that its stockholders voted to approve the previously announced business combination with Humacyte, Inc., a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale, and all other proposals presented at AHAC’s special shareholder’s meeting held on Augus

Humacyte Announces Addition of Chief Commercial Officer and Integration of Commercial-Scale Manufacturing into Clinical Trial Programs
17 Aug, 2021 Yahoo! Finance

Appoints proven commercial leader B.J. Scheessele as Chief Commercial OfficerIn-house Durham, N.C. facility is operational and supplying clinical trial material produced in commercial-scale manufacturing systemCompany’s proprietary modular manufacturing systems can produce an estimated 40,000+ vessels annually in current facility when scaled up DURHAM, N.C., Aug. 17, 2021 (GLOBE NEWSWIRE) -- Humacyte, Inc., a clinical-stage biotechnology platform company developing universally implantable bioeng

Humacyte Announces Publication of In Vivo Data on Biovascular Pancreas Transplantation for the Treatment of Type 1 Diabetes
11 Aug, 2021 Yahoo! Finance

Data demonstrate biovascular pancreas may have the potential to provide an effective and safe method for pancreatic islet cell transplantation for the treatment of type 1 diabetes Data published in the Journal of Tissue Engineering DURHAM, N.C., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Humacyte, Inc., a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale, announced laboratory and preclinical data demonstrating the potential to

Alpha Healthcare Acquisition Corp. Sets August 24, 2021, for Special Shareholder Meeting to Vote on Humacyte Business Combination
04 Aug, 2021 Yahoo! Finance

Special shareholder meeting to approve, among other items, the proposed business combination with Humacyte, Inc. to be held August 24, 2021, at 10:00 a.m. EDTShareholders as of the close of business on July 21, 2021, should vote their AHAC shares, no matter how many shares they ownAHAC recommends all shareholders vote “FOR” all proposals at the special shareholder meeting NEW YORK and DURHAM, N.C., Aug. 04, 2021 (GLOBE NEWSWIRE) -- Alpha Healthcare Acquisition Corp. (Nasdaq: AHAC) (“AHAC”), a sp

Humacyte Presents Potential of Functional Lung Engineering at Janelia R3 – Replace, Repair, Regenerate Planning Workshop
22 Jul, 2021 Yahoo! Finance

DURHAM, N.C., July 22, 2021 (GLOBE NEWSWIRE) -- Humacyte, Inc., a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale, today announces that Laura Niklason, M.D., Ph.D., Chief Executive Officer, delivered an invited presentation on laboratory and preclinical findings and notable criteria for engineering functional air sacs in the lungs, which support the potential to create engineered lung tissue organ, at the virtual Jan

Alpha Healthcare Acquisition Corp (AHACW) is a NASDAQ Common Stock listed in

970x250